Bloomington-based HealthPartners, a health insurer and owner and operator of clinics and hospitals in Minnesota, is planning to build a large orthopedic clinic in Woodbury, Minnesota. Called the Tria Orthopaedic Center, it will be a 75, 000 square feet space in a three story medical building. Total cost is expected by HealthPartners to be around $48 million.
Orthopedic Service Expansion Fuels Construction in Twin Cities
1 min read Premium comments
Secondary
Star Tribune writer Christopher Snowbeck wrote that the development is the latest example of how patient demand for joint replacements is fueling new construction across the Twin Cities.
Snowbeck quoted Ed Craig, M.D., the chief executive at TRIA Orthopaedic, as saying: “Orthopedics is probably the fastest growing area of medicine, with our baby boomers aging and staying active longer. The demand for orthopedic services keeps expanding, and will continue to expand over the next 20 years.”
The move will place Tria’s doctors in closer contact with their competitors at St. Croix Orthopaedics whose doctors send their patients to the HealthPartners hospital in Stillwater. Also in the Twin Cities is the Golden Valley-based Twin Cities Orthopedics which is planning to build a new sports medicine clinic in Eden Prairie as well as expand into Maple Grove and Plymouth. Recently Twin Cities Orthopedics announced a merger with St. Croix Orthopaedics.
Just last year, 2014, the Mayo Clinic opened a sports medicine clinic in downtown Minneapolis while Summit Orthopedics opened a new center in Vadnais Heights. St. Croix Orthopaedics plans to open a new sports medicine clinic in Eden Prairie, as well as also moving, with its new partners, into larger clinic spaces in Maple Grove and Plymouth.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.